A Study of Paravertebral Block in Thoracic Outlet Syndrome

Part of paid clinical trials in Jacksonville, Florida.

Sponsor
Mayo Clinic
Study ID
NCT05544721
Phase
PHASE4
Status
Enrolling By Invitation

Conditions

  • Thoracic Outlet Syndrome

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Ropivacaine — DRUG
    0.5% 3-4 mL per level, with levels T1 and T2 will be used as the block injectate

Study Details

This research is being done to evaluate the effects of receiving only a paravertebral block prior to first rib resection procedure versus receiving the block both pre and post procedure.

Key Dates

Start date
Oct 5, 2022
Status verified
Nov 2025
Primary completion
Aug 31, 2027
Completion
Aug 31, 2027

Study Design

Enrollment
50 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Active Comparator: Paravertebral block pre procedure
    Subjects will receive a preoperative paravertebral block only
  • Active Comparator: Paravertebral block pre and post procedure
    Subjects will receive one paravertebral block, administered preoperatively and one paravertebral block, administered on postoperative day 1

Primary Outcome Measure

Change in pain level [ Time Frame: Time of discharge (approximately 1 day), day 1 post-op, day 3 post-op, day 7 post-op, and day 14 post-op ]

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in FloridaJacksonvilleFlorida32224-

Find similar trials in Jacksonville, FL

By research site
Mayo Clinic in Florida· Jacksonville, FL

Related Studies